Protease Inhibitor-Induced Diabetic Complications: Incidence, Management and Prevention

By Lien Lillian F.   Feinglos Mark N.  

Drug Safety, Vol. 28, Iss. 3, 2005-01 ,pp. : 209-226

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis

By Mahmoudpour Seyed Hamidreza   Leusink Maarten   Putten Lisa van der   Terreehorst Ingrid   Asselbergs Folkert W   de Boer Anthonius   Maitland-van der Zee Anke H  

Pharmacogenomics, Vol. 14, Iss. 3, 2013-02 ,pp. : 249-260

Future Medicine

Access to resources Recommend Favorite

Drug-Induced Angioedema without Urticaria: Incidence, Prevention and Management

By Agostoni A.   Cicardi M.  

Drug Safety, Vol. 24, Iss. 8, 2001-01 ,pp. : 599-605

Adis International

Access to resources Recommend Favorite

Can Angiotensin Receptor Antagonists Be Used Safely in Patients with Previous ACE Inhibitor-Induced Angioedema?

By Howes L.G.  

Drug Safety, Vol. 25, Iss. 2, 2002-01 ,pp. : 73-76

Adis International

Access to resources Recommend Favorite

Drug-Induced Parkinsonism in the Elderly: Incidence, Management and Prevention

By López-Sendón José Luis   Mena María Angeles   de Yébenes Justo García  

Drugs & Aging, Vol. 29, Iss. 2, 2012-02 ,pp. : 105-118

Adis International

Access to resources Recommend Favorite